Skip to main content
HCPCS J2700 · Level II · Part B drug

J2700: oxacillin sodium (Bactocill In Dextrose), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2700

Billing unit
250 MG
Oxacillin sodium injeciton
ASP payment limit
$0.768
October 2026; +0.7% vs July 2026
Practitioner MUE
48
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J2700 is the Level II code for Injection, oxacillin sodium, up to 250 mg, billed per 250 MG. The Medicare Part B ASP payment limit for October 2026 is $0.768 per billing unit, up 0.7% from July 2026. The practitioner MUE allows up to 48 units per date of service (MAI 3), so a full 48-unit day is $36.86 at the current limit. Under OPPS it carries status indicator N. J2700 is billed in units of 250 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 14 NDCs to it, sold as Bactocill In Dextrose, Oxacillin Sodium by Baxter Healthcare Corporation, Sagent Pharmaceuticals, Eugia US LLC. No current Billing and Coding Article lists J2700, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2700 at $0.768 per 250 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.763 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2700
QuarterPayment limitPerCoinsurance
October 2026$0.768250 MG20%
July 2026$0.763250 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 14 NDCs from 5 labelers to J2700. Report the NDC in the claim's drug segment and bill the number of J2700 units that equals the quantity administered divided by 250 MG; the last column gives units per full package.

NDCs that crosswalk to J2700
NDCDrug nameLabelerPackage sizeBilling units / package
00338-1015-41Bactocill In DextroseBaxter Healthcare Corporation50 × 18
25021-0146-10Oxacillin SodiumSagent Pharmaceuticals1 × 1040
25021-0162-24Oxacillin SodiumSagent Pharmaceuticals1 × 1080
25021-0162-68Oxacillin SodiumSagent Pharmaceuticals1 × 1080
25021-0163-68Oxacillin SodiumSagent Pharmaceuticals1 × 10400
25021-0163-97Oxacillin SodiumSagent Pharmaceuticals1 × 140
25021-0163-99Oxacillin SodiumSagent Pharmaceuticals1 × 10400
55150-0127-15Oxacillin SodiumEugia US LLC1 × 1040
55150-0128-24Oxacillin SodiumEugia US LLC1 × 1080
55150-0129-99Oxacillin SodiumEugia US LLC1 × 140
63323-0811-00Oxacillin SodiumFreseniUS Kabi USA, LLC1 × 140
63323-0812-20Oxacillin SodiumFreseniUS Kabi USA, LLC1 × 1080
63323-0813-20Oxacillin SodiumFreseniUS Kabi USA, LLC1 × 1040
72485-0409-10Oxacillin SodiumArmas Pharmaceuticals Inc.1 × 1080

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2700. For practitioners the limit is 48 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2700 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services483 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital483 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J2700 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2700 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2700 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2700 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2700 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2700 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2700 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J2700 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2700

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2700

What does HCPCS code J2700 describe?

J2700 is defined by CMS as "Injection, oxacillin sodium, up to 250 mg". Each billing unit represents 250 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2700 a CPT code?

No. J2700 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as oxacillin sodium (Bactocill In Dextrose); CPT codes are five-character codes maintained by the AMA. On a Part B claim J2700 reports the drug itself in 250 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2700 in October 2026?

The ASP-based payment limit is $0.768 per 250 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.763. Commercial payers use their own fee schedules.

How many units of J2700 can be billed per day?

The practitioner Medically Unlikely Edit is 48 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J2700?

The October 2026 ASP crosswalk lists 14 NDCs from 5 labelers: Bactocill In Dextrose (Baxter Healthcare Corporation); Oxacillin Sodium (Sagent Pharmaceuticals); Oxacillin Sodium (Eugia US LLC); Oxacillin Sodium (FreseniUS Kabi USA, LLC). For example NDC 00338-1015-41 (package size 50) equals 8 billing units of J2700.

Does J2700 have NCCI bundling edits?

No active practitioner PTP pairs list J2700 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.